Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients
Clinical trial NCT02383030 · UNKNOWN
Trial details
- NCT number
- NCT02383030
- Sponsor
- Consorzio Oncotech
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2017-09-01
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.